Mean LoS (days) | 95% CI (lower) | 95% CI (upper) | p Value* | |
---|---|---|---|---|
Overall | 5.25 | 4.63 | 5.95 | |
Gender | ||||
Female | 5.57 | 4.85 | 6.40 | 0.0482 |
Male | 4.95 | 4.31 | 5.67 | |
Diabetes type | ||||
1 | 5.46 | 4.62 | 6.45 | 0.3103 |
2 | 5.04 | 4.46 | 5.71 | |
OAD regimen | ||||
Metformin | 4.53 | 3.73 | 5.50 | 0.0275 |
Sulfonylureas/glinides | 6.07 | 4.34 | 8.49 | |
Other OAD | 4.86 | 4.24 | 5.57 | |
No OAD | 5.68 | 5.10 | 6.32 |
*p Values for categorical variables retained in the generalized linear model analysis of potential risk factors. p Values indicate the level of significance for each variable's influence on the outcome.
LoS, length of stay; OAD, oral antidiabetic drug.